title: Development trends for human monoclonal antibody therapeutics.
abstract: Fully human monoclonal antibodies (mAbs) are a promising and rapidly growing category of targeted therapeutic agents. The first such agents were developed during the 1980s, but none achieved clinical or commercial success. Advances in technology to generate the molecules for study - in particular, transgenic mice and yeast or phage display - renewed interest in the development of human mAbs during the 1990s. In 2002, adalimumab became the first human mAb to be approved by the US Food and Drug Administration (FDA). Since then, an additional six human mAbs have received FDA approval: panitumumab, golimumab, canakinumab, ustekinumab, ofatumumab and denosumab. In addition, 3 candidates (raxibacumab, belimumab and ipilimumab) are currently under review by the FDA, 7 are in Phase III studies and 81 are in either Phase I or II studies. Here, we analyse data on 147 human mAbs that have entered clinical study to highlight trends in their development and approval, which may help inform future studies of this class of therapeutic agents.
authors.affiliation: Tufts University School of Medicine, Boston, Massachusetts 02118, USA.
authors.forename: Aaron L
authors.initials: AL
authors.lastname: Nelson
authors.forename: Eugen
authors.initials: E
authors.lastname: Dhimolea
authors.forename: Janice M
authors.initials: JM
authors.lastname: Reichert
mesh_terms: D000068879:Adalimumab; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001327:Autoimmune Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000639:trends; D017277:Drug Approval; D055808:Drug Discovery / Q000639:trends*; D006801:Humans
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C511911:belimumab; D000068879:Adalimumab
references.citation: MAbs. 2010 May-Jun;2(3):256-65
references.pmid: 20400861
references.citation: Nature. 1990 Dec 6;348(6301):552-4
references.pmid: 2247164
references.citation: Trends Immunol. 2007 Nov;28(11):482-90
references.pmid: 17964218
references.citation: MAbs. 2009 Jul-Aug;1(4):326-31
references.pmid: 20068404
references.citation: Nature. 1991 Aug 15;352(6336):624-8
references.pmid: 1907718
references.citation: Ann Intern Med. 1994 Jul 1;121(1):58-60
references.pmid: 8198349
references.citation: N Engl J Med. 2009 Jun 4;360(23):2416-25
references.pmid: 19494217
references.citation: J Clin Oncol. 2007 May 1;25(13):1658-64
references.pmid: 17470858
references.citation: Nat Biotechnol. 1996 Mar;14(3):309-14
references.pmid: 9630891
references.citation: J Immunol Methods. 1999 Dec 10;231(1-2):11-23
references.pmid: 10648924
references.citation: Nat Biotechnol. 2007 May;25(5):555-61
references.pmid: 17483842
references.citation: Neurol Sci. 2002 Apr;23 Suppl 1:S1-8
references.pmid: 12032582
references.citation: Proc Natl Acad Sci U S A. 1985 Mar;82(6):1790-4
references.pmid: 3856860
references.citation: Arch Dermatol. 2010 Feb;146(2):127-32
references.pmid: 20157022
references.citation: Nat Genet. 1994 May;7(1):13-21
references.pmid: 8075633
references.citation: J Immunol Methods. 1987 Jun 26;100(1-2):5-40
references.pmid: 3298441
references.citation: N Engl J Med. 2010 Aug 19;363(8):711-23
references.pmid: 20525992
references.citation: Nat Biotechnol. 2005 Sep;23(9):1073-8
references.pmid: 16151394
references.citation: MAbs. 2009 May-Jun;1(3):210-5
references.pmid: 20065634
references.citation: Methods. 2005 May;36(1):3-10
references.pmid: 15848070
references.citation: Arthritis Rheum. 2009 Sep 15;61(9):1168-78
references.pmid: 19714604
references.citation: Nat Rev Drug Discov. 2007 May;6(5):349-56
references.pmid: 17431406
references.citation: Rheumatol Int. 2007 Jan;27(3):269-74
references.pmid: 17006705
references.citation: Arthritis Rheum. 2003 Jan;48(1):35-45
references.pmid: 12528101
references.citation: J Pharm Biomed Anal. 2010 Jan 5;51(1):252-4
references.pmid: 19679421
references.citation: Nat Rev Rheumatol. 2010 Mar;6(3):124-5
references.pmid: 20197774
references.citation: Curr Pharm Biotechnol. 2008 Dec;9(6):423-30
references.pmid: 19075682
references.citation: Nat Rev Drug Discov. 2006 Mar;5(3):191-5
references.pmid: 16518372
references.citation: Proc Natl Acad Sci U S A. 1982 Nov;79(21):6651-5
references.pmid: 6292911
references.citation: Drug Discov Today. 2004 Jan 15;9(2):82-90
references.pmid: 15012932
references.citation: J Immunol. 2006 Jul 1;177(1):362-71
references.pmid: 16785532
references.citation: N Engl J Med. 2003 Feb 13;348(7):601-8
references.pmid: 12584368
references.citation: N Engl J Med. 2008 Mar 13;358(11):1109-17
references.pmid: 18337601
references.citation: MAbs. 2010 Jan-Feb;2(1):84-100
references.pmid: 20065640
references.citation: N Engl J Med. 1991 Feb 14;324(7):429-36
references.pmid: 1988827
references.citation: MAbs. 2010 Jan-Feb;2(1):3-13
references.pmid: 20065636
references.citation: J Clin Invest. 1982 Jul;70(1):205-8
references.pmid: 7085884
references.citation: Mol Immunol. 2007 Sep;44(16):3823-37
references.pmid: 17768100
references.citation: Nat Biotechnol. 2005 Sep;23(9):1117-25
references.pmid: 16151405
references.citation: Ann Intern Med. 1994 Jul 1;121(1):1-5
references.pmid: 8198341
references.citation: J Exp Med. 1984 Feb 1;159(2):537-50
references.pmid: 6582214
references.citation: Ann Rheum Dis. 2007 Jul;66(7):921-6
references.pmid: 17301106
references.citation: Clin Colorectal Cancer. 2006 Jul;6(2):118-24
references.pmid: 16945167
references.citation: MAbs. 2009 Jul-Aug;1(4):332-8
references.pmid: 20073133
references.citation: MAbs. 2009 Nov-Dec;1(6):531-8
references.pmid: 20068396
references.citation: J Immunol. 2007 Jun 1;178(11):7467-72
references.pmid: 17513798
references.citation: MAbs. 2009 Sep-Oct;1(5):422-31
references.pmid: 20065639
references.citation: Cancer Chemother Pharmacol. 2009 May;63(6):1017-22
references.pmid: 18781300
references.citation: Proc Natl Acad Sci U S A. 1980 Sep;77(9):5429-31
references.pmid: 6159646
references.citation: Nature. 1994 Apr 28;368(6474):856-9
references.pmid: 8159246
references.citation: Crit Care Med. 1993 Aug;21(8):1233-41
references.pmid: 8339592
references.citation: MAbs. 2009 May-Jun;1(3):216-21
references.pmid: 20069753
references.citation: Semin Thromb Hemost. 2000;26(2):151-5
references.pmid: 10919407
references.citation: J Immunol. 1981 Oct;127(4):1275-80
references.pmid: 6268704